Endomatic

Endovascular Left Atrial Appendage Closure Device

Startup

Endomatic is a Or Yehuda-based startup in the Health Tech & Life Sciences sector, established in 2018. Endovascular Left Atrial Appendage Closure Device. The company has raised a total of $1M across 4 funding rounds, currently at the Seed stage. Endomatic was founded by Boaz Schwarz. Key investors include Peregrine Ventures. The company has 1-10 employees.

With $1M in total funding, Endomatic is a Seed-stage company operating in Health Tech & Life Sciences. The company follows a B2B business model. Product stage: R&D. The company holds 1 patent.

$1M
Raised
4
Rounds
1
Investors
1
Team
2018
Founded
1
Patents
Sector & Technology
Health Tech & Life SciencesMedical DevicesMedical Treatment & Therapeutics
At a Glance
Investors
Founders
Frequently Asked Questions
What does Endomatic do?

Endomatic develops a break through endovascular Left Atrial Appendage (“LAA”) closure device to prevent stroke. Since a clot formation in the LAA is the primary cause for stroke in Atrial Fibralation patients, the interventional cardiologists and electrophysiologists routinely perform procedures which occlude the LAA with an implantable device. As the implant come in contact with the heart’s flowing blood it may lead to device related thrombus (DRT), which is the clinicians highest concern, since it means that such procedures actively induce the stroke risk. Endomatic patented technology expects to eliminate the risk of DRT due to its non-thrombogenic nature. The company is endorsed with the top clinicians, including a world leader practitioner who became the head of its SAB and an investor.

How much funding has Endomatic raised?

Endomatic has raised $1M in total funding across 4 rounds. The company is currently at the Seed stage. Key investors include Peregrine Ventures.

Who founded Endomatic?

Endomatic was founded in 2018 by Boaz Schwarz (Co-founder & CEO).

What sector is Endomatic in?

Endomatic operates in Health Tech & Life Sciences, Medical Devices, Medical Treatment & Therapeutics. Target customers: Healthcare & Life Sciences, Healthcare, Providers.

Where is Endomatic located?

Endomatic is based in Or Yehuda, Israel.

View Full Profile Classic View